ID

34233

Beschreibung

Angiogenic Factor Expression During Fractionated Irradiation; ODM derived from: https://clinicaltrials.gov/show/NCT02072720

Link

https://clinicaltrials.gov/show/NCT02072720

Stichworte

  1. 15.01.19 15.01.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

15. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Primary Esophageal Carcinoma NCT02072720

Eligibility Primary Esophageal Carcinoma NCT02072720

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients that will receive chemoradiation following cross-schedule before surgery for esophageal carcinoma
Beschreibung

Chemoradiotherapy | Operative Surgical Procedures Esophageal carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0436307
UMLS CUI [2,1]
C0543467
UMLS CUI [2,2]
C0152018
ability to give informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
age 18 years or older
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
evidence of bleeding diathesis, coagulopathy
Beschreibung

Bleeding tendency | Blood Coagulation Disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
inflammation of the gi-tract
Beschreibung

Gastrointestinal inflammation

Datentyp

boolean

Alias
UMLS CUI [1]
C1535950
brain metastases
Beschreibung

Metastatic malignant neoplasm to brain

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
diastolic/ systolic hypertension, not responding to treatment
Beschreibung

Diastolic hypertension Unresponsive to Treatment | Systolic hypertension Unresponsive to Treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0235222
UMLS CUI [1,2]
C0205269
UMLS CUI [2,1]
C0221155
UMLS CUI [2,2]
C0205269
arterial thromboembolism in medical history
Beschreibung

Arterial thromboembolism

Datentyp

boolean

Alias
UMLS CUI [1]
C3544094
surgery within the month prior to start of bevacizumab treatment
Beschreibung

Operative Surgical Procedures

Datentyp

boolean

Alias
UMLS CUI [1]
C0543467

Ähnliche Modelle

Eligibility Primary Esophageal Carcinoma NCT02072720

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Chemoradiotherapy | Operative Surgical Procedures Esophageal carcinoma
Item
patients that will receive chemoradiation following cross-schedule before surgery for esophageal carcinoma
boolean
C0436307 (UMLS CUI [1])
C0543467 (UMLS CUI [2,1])
C0152018 (UMLS CUI [2,2])
Informed Consent
Item
ability to give informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Bleeding tendency | Blood Coagulation Disorder
Item
evidence of bleeding diathesis, coagulopathy
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Gastrointestinal inflammation
Item
inflammation of the gi-tract
boolean
C1535950 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])
Diastolic hypertension Unresponsive to Treatment | Systolic hypertension Unresponsive to Treatment
Item
diastolic/ systolic hypertension, not responding to treatment
boolean
C0235222 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0221155 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
Arterial thromboembolism
Item
arterial thromboembolism in medical history
boolean
C3544094 (UMLS CUI [1])
Operative Surgical Procedures
Item
surgery within the month prior to start of bevacizumab treatment
boolean
C0543467 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video